Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 489758, 8 pages
http://dx.doi.org/10.1155/2015/489758
Review Article

Experimental Vaccines against Chagas Disease: A Journey through History

1Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1, Colonia Sección XVI, 14080 Delegación Tlalpan, DF, Mexico City, Mexico
2Centro de Investigaciones Biomédicas, Universidad Autónoma de Campeche, Avenida Agustín Melgar No. 3, 24030 Campeche, CAM, Mexico
3Centro de Investigaciones en Ciencias Microbiológicas, Benemérita Universidad Autónoma de Puebla, 14 Sur y Avenida San Claudio, Ciudad Universitaria, 72570 Puebla, PUE, Mexico

Received 3 March 2015; Revised 21 April 2015; Accepted 27 April 2015

Academic Editor: Xiao-Feng Yang

Copyright © 2015 Olivia Rodríguez-Morales et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Weekly epidemiological record,” vol. 87, no. 51-52, pp. 509–526, 2012, http://www.who.int/wer.
  2. L. V. Kirchhoff, “American trypanosomiasis (Chagas' disease)—a tropical disease now in the United States,” The New England Journal of Medicine, vol. 329, no. 9, pp. 639–644, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Wizel, N. Garg, and R. L. Tarleton, “Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection,” Infection and Immunity, vol. 66, no. 11, pp. 5073–5081, 1998. View at Google Scholar · View at Scopus
  4. R. L. Tarleton and J. W. Curran, “Is Chagas disease really the ‘new HIV/AIDS of the Americas’?” PLoS Neglected Tropical Diseases, vol. 6, no. 10, Article ID e1861, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. J. Esch and C. A. Petersen, “Transmission and epidemiology of zoonotic protozoal diseases of companion animals,” Clinical Microbiology Reviews, vol. 26, no. 1, pp. 58–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Romero-Dávalos, Enfermedad de Chagas, Editorial Los Amigos del Libro, La Paz, Bolivia, 1979.
  7. T. Pizzi and R. Prager, “Immunity to infection induced by culture of Trypanosoma cruzi of atenuated virulence; preliminary communication,” Boletín Informativo de Parasitolgía Chilena, vol. 7, no. 2, pp. 20–21, 1952. View at Google Scholar
  8. S. M. González Cappa, G. A. Schmuñis, O. C. Traversa, J. F. Yanovsky, and A. S. Parodi, “Complement-fixation tests, skin tests, and experimental immunization with antigens of Trypanosoma cruzi prepared under pressure,” The American Journal of Tropical Medicine and Hygiene, vol. 17, no. 5, pp. 709–715, 1968. View at Google Scholar · View at Scopus
  9. H. Menezes, “Protective effect of an avirulent (cultivated) strain of Trypanosoma cruzi against experimental infection in mice,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 10, no. 1, pp. 1–4, 1968. View at Google Scholar · View at Scopus
  10. M. V. Introini, B. Basso, and E. Moretti, “Experimental Chagas' disease: I. Study of different immunization conditions in the infection course,” Boletín chileno de parasitología, vol. 53, no. 3-4, pp. 45–51, 1998. View at Google Scholar · View at Scopus
  11. J. W. Breganó, R. C. Picão, V. K. Graça et al., “Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi that are recognized by human sera and induce protective immunity in mice,” FEMS Immunology & Medical Microbiology, vol. 39, no. 3, pp. 257–264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pinge-Filho, J. P. S. Peron, T. R. de Moura et al., “Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide,” Immunology Letters, vol. 96, no. 2, pp. 283–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Basso, E. Moretti, and R. Fretes, “Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection,” Memórias do Instituto Oswaldo Cruz, vol. 103, no. 4, pp. 370–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Basso, E. Moretti, and R. Fretes, “Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi,” Veterinary Immunology and Immunopathology, vol. 157, no. 1-2, pp. 119–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Perez Brandan, A. M. Padilla, D. Xu, R. L. Tarleton, and M. A. Basombrio, “Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge,” PLoS Neglected Tropical Diseases, vol. 5, no. 12, article e1418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. Rosas-Jorquera, L. R. Sardinha, F. D. Pretel, A. L. Bombeiro, M. R. D. Lima, and J. M. Alvarez, “Challenge of chronically infected mice with homologous Trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine,” Clinical and Vaccine Immunology, vol. 20, no. 2, pp. 248–254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Ruiz, M. Esteva, P. Cabeza Meckert, R. P. Laguens, and E. L. Segura, “Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi,” Acta Tropica, vol. 42, no. 4, pp. 299–309, 1985. View at Google Scholar · View at Scopus
  18. R. A. Wrightsman, M. J. Miller, J. L. Saborio, and J. E. Manning, “Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection,” Infection and Immunity, vol. 63, no. 1, pp. 122–125, 1995. View at Google Scholar · View at Scopus
  19. M. J. Miller, R. A. Wrightsman, and J. E. Manning, “Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response,” Experimental Parasitology, vol. 84, no. 2, pp. 156–167, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Snary, “Cell surface glycoproteins of Trypanosoma cruzi: protective immunity in mice and antibody levels in human chagasic sera,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 77, no. 1, pp. 126–129, 1983. View at Publisher · View at Google Scholar · View at Scopus
  21. F. G. Araujo and B. Morein, “Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against letal challenge in mice,” Infection and Immunity, vol. 59, no. 9, pp. 2909–2914, 1991. View at Google Scholar · View at Scopus
  22. Y. M. Gomes, F. G. C. Abath, M. Nakazawa, P. Minoprio, I. Vouldoukis, and L. Monjour, “Partial protection of mice against Trypanosoma cruzi after immunizing with the TcY 72 antigenic preparation,” Memórias do Instituto Oswaldo Cruz, vol. 94, no. 2, pp. 167–172, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Taibi, B. Plumas-Marty, A. Guevara-Espinoza et al., “Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity,” The Journal of Immunology, vol. 151, no. 5, pp. 2676–2689, 1993. View at Google Scholar · View at Scopus
  24. A. Gruppi, F. Cerban, M. C. Pistoresi-Palencia, and E. Vottero-Cima, “Trypanosoma cruzi: transfer of protection by lymph node cells obtained from mice immunized with exoantigens of pI 4.5,” Experimental Parasitology, vol. 80, no. 3, pp. 382–389, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. A. C. Garcia, E. C. Oliveira, J. K. Sakurada, and L. M. B. Santos, “Protective immunity induced by a Trypanosoma cruzi soluble extract antigen in experimental Chagas' disease. Role of interferon γ,” Immunological Investigations, vol. 29, no. 1, pp. 1–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. V. R. A. Pereira, V. M. B. Lorena, A. F. A. Verçosa et al., “Antibody isotype responses in BALB/c mice immunized with the cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi,” Memorias do Instituto Oswaldo Cruz, vol. 98, no. 6, pp. 823–825, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Luhrs, D. L. Fouts, and J. E. Manning, “Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection,” Vaccine, vol. 21, no. 21-22, pp. 3058–3069, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. C. Vasconcelos, S. B. Boscardin, M. I. Hiyane, S. S. Kinoshita, A. E. Fujimura, and M. M. Rodrigues, “A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain,” Immunology and Cell Biology, vol. 81, no. 2, pp. 121–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. I. Cazorla, F. M. Frank, P. D. Becker et al., “Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection,” The Journal of Infectious Diseases, vol. 202, no. 1, pp. 136–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Flores-García, J. L. Rosales-Encina, A. R. Satoskar, and P. Talamás-Rohana, “IL-10-IFN-γ double producers CD4+ T cells are induced by immunization with an amastigote stage specific derived recombinant protein of Trypanosoma cruzi,” International Journal of Biological Sciences, vol. 7, no. 8, pp. 1093–1100, 2011. View at Google Scholar · View at Scopus
  31. A. Carabarin-Lima, M. C. González-Vázquez, L. Baylon-Pacheco, V. Tsutsumi, P. Talamás-Rohana, and J. L. Rosales-Encina, “Immunization with the recombinant surface protein rTcSP2 alone or fused to the CHP or ATPase domain of TcHSP70 induces protection against acute Trypanosoma cruzi infection,” Journal of Vaccines & Vaccination, vol. 1, no. 3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. I. A. Bontempi, M. H. Vicco, G. Cabrera et al., “Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease,” Vaccine, vol. 33, no. 10, pp. 1274–1283, 2015. View at Publisher · View at Google Scholar
  33. J. L. Dutton, B. Li, W.-P. Woo et al., “A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice,” PLoS ONE, vol. 8, no. 10, Article ID e76407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Lu, A. Zhou, M. Meng et al., “Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii,” BMC Infectious Diseases, vol. 14, no. 1, p. 3862, 2014. View at Publisher · View at Google Scholar
  35. S. Qiu, X. Ren, Y. Ben et al., “Fusion-expressed CTB improves both systemic and mucosal T-cell responses elicited by an intranasal DNA priming/intramuscular recombinant vaccinia boosting regimen,” Journal of Immunology Research, vol. 2014, Article ID 308732, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Dong, D. S. Zarlenga, and X. Ren, “An overview of live attenuated recombinant pseudorabies viruses for use as novel vaccines,” Journal of Immunology Research, vol. 2014, Article ID 824630, 10 pages, 2014. View at Publisher · View at Google Scholar
  37. Y. Xu, N. Z. Zhang, Q. D. Tan et al., “Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model,” BMC Infectious Diseases, vol. 14, no. 1, article 525, 2014. View at Publisher · View at Google Scholar
  38. B. Salgado-Jiménez, M. Arce-Fonseca, L. Baylón-Pacheco, P. Talamás-Rohana, and J. L. Rosales-Encina, “Differential immune response in mice immunized with the A, R or C domain from TcSP protein of Trypanosoma cruzi or with the coding DNAs,” Parasite Immunology, vol. 35, no. 1, pp. 32–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Arce-Fonseca, A. Ramos-Ligonio, A. López-Monteón, B. Salgado- Jiménez, P. Talamás-Rohana, and J. L. Rosales-Encina, “A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas disease,” International Journal of Biological Sciences, vol. 7, no. 9, pp. 1230–1238, 2011. View at Google Scholar · View at Scopus
  40. M. Arce-Fonseca, M. A. Ballinas-Verdugo, E. R. A. Zenteno et al., “Specific humoral and cellular immunity induced by Trypanosoma cruzi DNA immunization in a canine model,” Veterinary Research, vol. 44, no. 1, article 15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Rodríguez-Morales, M. M. Pérez-Leyva, M. A. Ballinas-Verdugo et al., “Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model,” Veterinary Research, vol. 43, no. 1, article 79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Rodríguez-Morales, S. C. Carrillo-Sánchez, H. García-Mendoza et al., “Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine Model,” BioMed Research International, vol. 2013, Article ID 826570, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Gupta and N. J. Garg, “TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice,” PLoS ONE, vol. 8, no. 3, Article ID e59434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. R. T. Nogueira, A. R. Nogueira, M. C. S. Pereira et al., “Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi,” PLoS ONE, vol. 8, no. 3, Article ID e59347, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. I. A. Quijano-Hernández, A. Castro-Barcena, J. C. Vázquez-Chagoyán, M. E. Bolio-González, J. Ortega-López, and E. Dumonteil, “Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi,” Vaccine, vol. 31, no. 18, pp. 2246–2252, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Gupta, T. S. Silva, J. E. Osizugbo, L. Tucker, H. M. Spratt, and N. J. Garg, “Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against chagas disease,” Infection and Immunity, vol. 82, no. 4, pp. 1382–1389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. J. R. Vasconcelos, M. R. Dominguez, R. L. Neves et al., “Adenovirus vector-induced CD8+ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi infection,” Human Gene Therapy, vol. 25, no. 4, pp. 350–363, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. S. I. Cazorla, M. N. Matos, N. Cerny et al., “Oral multicomponent DNA vaccine delivered by attenuated salmonella elicited immunoprotection against American trypanosomiasis,” The Journal of Infectious Diseases, vol. 211, no. 5, pp. 698–707, 2015. View at Publisher · View at Google Scholar
  49. S. I. Cazorla, F. M. Frank, and E. L. Malchiodi, “Vaccination approaches against Trypanosoma cruzi infection,” Expert Review of Vaccines, vol. 8, no. 7, pp. 921–935, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. P. J. Hotez, A. Fenwick, L. Savioli, and D. H. Molyneux, “Rescuing the bottom billion through control of neglected tropical diseases,” The Lancet, vol. 373, no. 9674, pp. 1570–1575, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Dumonteil, M. E. Bottazzi, B. Zhan et al., “Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects,” Expert Review of Vaccines, vol. 11, no. 9, pp. 1043–1055, 2012. View at Publisher · View at Google Scholar · View at Scopus